| PERIOD ENDING | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | 3-Oct-08 | | Total Revenue | 32,545 | 28,533 | 30,731 | 51,101 | | Cost of Revenue | 12,618 | 14,530 | 9,749 | 12,974 | | | Gross Profit | 19,927 | 14,003 | 20,982 | 38,127 | | | Operating Expenses | | Research Development | 12,097 | 13,100 | 13,344 | 14,024 | | Selling General and Administrative | 9,880 | 10,702 | 11,123 | 12,608 | | Non Recurring | 9 | 4,582 | 2,305 | (73) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,059) | (14,381) | (5,790) | 11,568 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (285) | 415 | 2,801 | 419 | | Earnings Before Interest And Taxes | (2,344) | (13,966) | (2,989) | 11,987 | | Interest Expense | 462 | 433 | 469 | 671 | | Income Before Tax | (2,806) | (14,399) | (3,458) | 11,316 | | Income Tax Expense | 127 | 172 | 90 | 332 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,933) | (14,571) | (3,548) | 10,984 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,933) | (14,571) | (3,548) | 10,984 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,933) | ($14,571) | ($3,548) | $10,984 |
|
0.29% Nasdaq 0.00%
Income Statement
